Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are there curative options to peritoneal carcinomatosis?

Literature DB >> 16244553

Are there curative options to peritoneal carcinomatosis?

Paul H Sugarbaker.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 16244553 PMCID： PMC1409866 DOI： 10.1097/00000658-200511000-00023

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

14 in total

1. Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.

Authors: P H Sugarbaker; K Kern; E Lack
Journal: Dis Colon Rectum Date: 1987-10 Impact factor: 4.585

2. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.

Authors: P H Sugarbaker; D Chang
Journal: Ann Surg Oncol Date: 1999-12 Impact factor: 5.344

3. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.

Authors: P Piso; H Bektas; U Werner; H J Schlitt; S Kubicka; A Bornscheuer; M Manns; J Klempnauer
Journal: Eur J Surg Oncol Date: 2001-04 Impact factor: 4.424

4. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.

Authors: Rasmy Loungnarath; Sylvain Causeret; Nadine Bossard; Mohamed Faheez; Annie-Claude Sayag-Beaujard; Cécile Brigand; François Gilly; Olivier Glehen
Journal: Dis Colon Rectum Date: 2005-07 Impact factor: 4.585

5. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.

Authors: A J Witkamp; E de Bree; M M Kaag; G W van Slooten; F van Coevorden; F A Zoetmulder
Journal: Br J Surg Date: 2001-03 Impact factor: 6.939

6. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.

Authors: Marcello Deraco; Dario Baratti; Maria Grazia Inglese; Biagino Allaria; Salvatore Andreola; Cecilia Gavazzi; Shigeki Kusamura
Journal: Ann Surg Oncol Date: 2004-04 Impact factor: 5.344

7. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

Authors: O Glehen; F Kwiatkowski; P H Sugarbaker; D Elias; E A Levine; M De Simone; R Barone; Y Yonemura; F Cavaliere; F Quenet; M Gutman; A A K Tentes; G Lorimier; J L Bernard; J M Bereder; J Porcheron; A Gomez-Portilla; P Shen; M Deraco; P Rat
Journal: J Clin Oncol Date: 2004-08-15 Impact factor: 44.544

8. Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.

Authors: Joseph Misdraji; Rhonda K Yantiss; Fiona M Graeme-Cook; Ulysses J Balis; Robert H Young
Journal: Am J Surg Pathol Date: 2003-08 Impact factor: 6.394

9. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach.

Authors: D B Gough; J H Donohue; A J Schutt; N Gonchoroff; J R Goellner; T O Wilson; J M Naessens; P C O'Brien; J A van Heerden
Journal: Ann Surg Date: 1994-02 Impact factor: 12.969

10. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.

Authors: Perry Shen; Edward A Levine; Jason Hall; Doug Case; Greg Russell; Ronald Fleming; Richard McQuellon; Kim R Geisinger; Brian W Loggie
Journal: Arch Surg Date: 2003-01

3 in total